Andreas Wortmann, PhD, is a Senior Medical Science Liaison in Oncology at Eli Lilly and Company, where they have been since 2024. Prior to this role, Andreas held various positions in the medical and scientific fields, including Global Manager of Regulatory and Scientific Affairs at Novartis and Associate Research Fellow at the ARC Centre of Excellence for Electromaterials Science. They earned a PhD in Cell and Molecular Biosciences from Queensland University of Technology and have extensive experience in translational cancer research, clinical trial management, and medical affairs across multiple organizations. Andreas has also contributed to AI training relevant to biology and medical domains.
This person is not in the org chart
This person is not in any teams
This person is not in any offices